🔓 Unlock the full profile of Liang Schweizer (Hifibio Therapeutics), including verified contact details, financial insights, and professional associations.
See Liang Schweizer Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: lia*****@hif******.com
Mobile: 94931*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Liang Schweizer is the President and Founder of HiFiBiO Therapeutics, a biotechnology company based in Cambridge, Massachusetts, specializing in innovative therapies.
- Under Liang's leadership, HiFiBiO Therapeutics has been recognized for its groundbreaking work in biotherapeutics, which targets disease at the molecular level.
- Liang Schweizer co-founded HiFiBiO Therapeutics in 2013, aiming to leverage advanced technologies to transform patient care and improve treatment outcomes.
- Previously, Liang served as the Founder, Chairperson, and CEO of HiFiBiO from July 2017 until February 2025, guiding the company's strategic vision and operations.
- Before establishing HiFiBiO, Liang held significant roles, including Co-Founder and Chief Scientific Officer at HARBOUR BIOMED, contributing to the development of novel cancer therapies.
- Liang led the Asian Cancer Research division at Sanofi, where contributions helped advance pharmaceutical research in oncology.
- As a Director at Bristol Myers Squibb, Liang played a pivotal role in discovery and optimization efforts, strengthening the company's drug development pipeline.
- Liang’s early career included positions as an Adjunct Assistant Professor at Hunter College and a Research Fellow at Memorial Sloan-Kettering Cancer Center, focusing on eukaryotic genetics and cancer research.
- Through various leadership roles, Liang Schweizer has demonstrated a commitment to addressing significant challenges in cancer treatment and has been influential in the biotechnology industry.